Mechanisms of PFAS-Induced Renal Damage
Chronic kidney disease (CKD) involves progressive loss of functional nephrons — the filtration units of the kidney. PFAS damage nephrons through tubular toxicity (direct damage to the proximal tubule cells that concentrate PFAS during urinary excretion) and glomerular injury (damage to the filtration membranes that allow protein leak into urine). Both mechanisms contribute to CKD progression.
PFAS-induced mitochondrial dysfunction in tubular cells reduces their energy supply for active transport functions, impairing tubular reabsorption and accelerating tubular cell death. Oxidative stress from PFAS generates reactive oxygen species that damage tubular cell DNA and mitochondria in a self-amplifying cycle of progressive nephron loss.
Epidemiological Evidence for PFAS-CKD Associations
Cross-sectional analyses using NHANES data have found inverse associations between PFAS serum levels and estimated glomerular filtration rate (eGFR) — the standard measure of kidney function — across the U.S. adult population. Higher PFAS concentrations correlate with lower eGFR, suggesting PFAS contributes to reduced filtration function at population level.
A longitudinal analysis following a cohort of adults over 10 years found that higher baseline PFAS levels predicted faster eGFR decline and higher rates of incident CKD diagnosis. The association was strongest for PFOS and PFOA and was independent of hypertension, diabetes, and obesity — the most common CKD risk factors.
Nephrology Practice Implications
Nephrologists managing patients with CKD of uncertain etiology — or CKD progression faster than expected from conventional risk factors — should consider PFAS exposure history. In PFAS-contaminated communities, the background CKD progression rate may be elevated, and environmental exposure reduction could be a disease-modifying intervention.
For patients with CKD, reducing PFAS intake through water filtration removes the proximal tubule’s ongoing exposure to concentrated PFAS during urine production. Maintaining adequate hydration — supporting renal perfusion and diluting urine PFAS concentrations — is a complementary strategy. These measures do not reverse existing nephron loss but may slow ongoing PFAS-mediated damage.